Ascension Mercy

Patient Safety - All

Healthcare-Associated Infections

Hospitals in Illinois are participating in programs to reduce the number of infections acquired during hospital stays. While it is difficult to reduce infections to zero, following specific protocols can greatly reduce the risk.

The Hospital Report Card Act (Illinois Public Act 93-563) requires Illinois hospitals to report central line associated bloodstream infections (CLABSIs) as well as surgical site infections (SSIs). As of January 1, 2012, hospitals are also mandated to report Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections and Clostridioides difficileinfections. Infections are reported through the CDC’s National Healthcare Safety Network (NHSN) surveillance system. The Standardized Infection Ratio (SIR), a summary measure used to determine whether infection data are statistically different from the national average, is presented for each type of infection shown below. Read more about healthcare-associated infections in Illinois. To learn more about the data collection methods using the CDC's National Health Safety Network (NHSN) surveillance system, read the Report Card methodology.

Clostridioides difficile infections (CDI) and Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections

Facility-wide Healthcare Facility Onset Incidence Rates for CDI and MRSA are presented below. These rates are based on results of laboratory tests that were obtained on or after day four of an inpatient stay and do not consider presence or timing of clinical signs or symptoms. The Standardized Infection Ratio (SIR) is presented, which is a summary measure used to determine if rates of CDI and MRSA bloodstream infections are statistically different from the national average. Statewide summaries of CDI and MRSA data arranged by hospital are also included. Note: Starting with 2016 data, new methods for risk adjustment were used.

Statistical Significance

Statistically significantly better than state average or performing at the best possible rate

Not statistically significantly better or worse than state average

Statistically significantly worse than state average

Footnotes

Key	Description
33	Complete Reporting: 50 or Less Central Line Days
36	Incomplete Reporting
38	Exempt: No Licensed PICU Beds
39	Exempt: No Licensed NICU Beds
42	Complete Reporting: Zero infections, but too few central line days to calculate a precise SIR
45	Complete Reporting: Zero infections. Number of predicted LabID events too low to calculate a precise SIR
46	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
47	Complete Reporting: Number of predicted LabID events too low to calculate a precise SIR
49	Complete Reporting: 20 or Fewer Procedures Performed
114	Complete Reporting: Number of predicted events too low to calculate a precise SIR
117	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
118	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
153	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
154	Complete Reporting: Number of predicted events too low to calculate a precise SIR
169	Exempt: No Licensed ICU Beds

Central Line Associated Bloodstream Infections (CLABSIs)

Presented below are annual central line-associated bloodstream infections (CLABSIs) occurring in critical care units, also known as intensive care units (ICUs). ICU-specific summary data for CLABSI are provided using the Standardized Infection Ratio(SIR). Statewide summaries of CLABSI data arranged by ICU type and hospital are also included.

Statistical Significance

Statistically significantly better than state average or performing at the best possible rate

Not statistically significantly better or worse than state average

Statistically significantly worse than state average

Footnotes

Key	Description
33	Complete Reporting: 50 or Less Central Line Days
36	Incomplete Reporting
38	Exempt: No Licensed PICU Beds
39	Exempt: No Licensed NICU Beds
42	Complete Reporting: Zero infections, but too few central line days to calculate a precise SIR
45	Complete Reporting: Zero infections. Number of predicted LabID events too low to calculate a precise SIR
46	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
47	Complete Reporting: Number of predicted LabID events too low to calculate a precise SIR
49	Complete Reporting: 20 or Fewer Procedures Performed
114	Complete Reporting: Number of predicted events too low to calculate a precise SIR
117	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
118	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
153	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
154	Complete Reporting: Number of predicted events too low to calculate a precise SIR
169	Exempt: No Licensed ICU Beds

Adult CLABSI

Pediatric CLABSI

Ped. CLABSI Measure	Result	SIR
Pediatric Medical-Surgical ICU Q1 2019 - Q4 2019 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Description Central Line-associated Bloodstream Infection (CLABSI) data in the Medical-Surgical Pediatric ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2018 - Q4 2018 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Q1 2017 - Q4 2017 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Q1 2016 - Q4 2016 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2015 - Q4 2015 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2014 - Q4 2014 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2013 - Q4 2013 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2012 - Q4 2012 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2011 - Q4 2011 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2010 - Q4 2010 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2010 - Q2 2010 Result N/A infections, N/A central-line days ³⁸ Rating SIR: 0.00 ³⁸	N/A infections, N/A central-line days ³⁸	0.00 ³⁸

NICU CLABSI

Surgical Site Infections (SSIs)

Presented below are data for surgical site infections associated with coronary artery bypass graft surgery (CABG) and total knee replacement surgery (KPROs) using the Standardized Infection Ratio (SIR). Superficial and secondary surgical site infections are not included in the summary data below. Statewide summaries of surgical site infection data arranged by surgical procedure (CABG, KPRO) and hospital are also included.

Statistical Significance

Statistically significantly better than state average or performing at the best possible rate

Not statistically significantly better or worse than state average

Statistically significantly worse than state average

Footnotes

Key	Description
33	Complete Reporting: 50 or Less Central Line Days
36	Incomplete Reporting
38	Exempt: No Licensed PICU Beds
39	Exempt: No Licensed NICU Beds
42	Complete Reporting: Zero infections, but too few central line days to calculate a precise SIR
45	Complete Reporting: Zero infections. Number of predicted LabID events too low to calculate a precise SIR
46	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
47	Complete Reporting: Number of predicted LabID events too low to calculate a precise SIR
49	Complete Reporting: 20 or Fewer Procedures Performed
114	Complete Reporting: Number of predicted events too low to calculate a precise SIR
117	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
118	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
153	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
154	Complete Reporting: Number of predicted events too low to calculate a precise SIR
169	Exempt: No Licensed ICU Beds

Immunization Practices

Illinois hospitals are focusing their efforts on boosting immunization treatments and strengthening patient safety protocols. The objective is not merely achieving statistical success, but also enhancing the quality of care and patient well-being.

Data on immunization measures in Illinois hospitals is available through the Medicare comparison tool at medicare.gov/hospitalcompare. This tool provides valuable insights, allowing patients and their families to gauge the quality of care and safety practices at local hospitals, helping them make informed healthcare decisions.

In the realm of Patient Safety, a host of measures are assessed, with risk-adjusted rates available for each. These measures encompass various aspects of patient care and treatment outcomes. However, interpreting these metrics requires an understanding of the complexity and context-specific nature of healthcare.

Immunization

These indicators are used to measure immunization treatments at hospitals. This data comes from medicare.gov/hospitalcompare.

Measure	Result
Healthcare workers given influenza vaccination Q4 2022 - Q1 2023 Result 97.00 %	97.00 %
Description Influenza Vaccination Coverage among Healthcare Personnel Historical Data
Measure	Result
Q4 2021 - Q1 2022 Result 90.00 %	90.00 %
Q4 2020 - Q1 2021 Result 82.00 %	82.00 %
Q4 2019 - Q1 2020 Result 85.00 %	85.00 %
Q4 2018 - Q1 2019 Result 95.00 %	95.00 %
Q4 2017 - Q1 2018 Result 94.00 %	94.00 %

Illinois Hospital Report Card

and Consumer Guide to Health Care

Ascension Mercy

Patient Safety - All

Healthcare-Associated Infections

Clostridioides difficile infections (CDI) and Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections

Statistical Significance

Footnotes

Description

Historical Data

Description

Historical Data

Central Line Associated Bloodstream Infections (CLABSIs)

Statistical Significance

Footnotes

Adult CLABSI

Description

Historical Data

Pediatric CLABSI

Description

Historical Data

NICU CLABSI

Description

Historical Data

Description

Historical Data

Surgical Site Infections (SSIs)

Statistical Significance

Footnotes

Description

Historical Data

Description

Historical Data

Immunization Practices

Immunization

Description

Historical Data

Healthcare Facility Onset Incidence Rate	Result	SIR
Methicillin-resistant Staphylococcus aureus (MRSA) blood stream infections Q1 2023 - Q4 2023 Result 1 infections, 23907 patient days Rating SIR: N/A	1 infections, 23907 patient days	N/A
Description Methicillin-resistant Staphylococcus aureus infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 0 infections, 26592 patient days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 26592 patient days ¹¹⁷	0.00 ¹¹⁷
Q1 2021 - Q4 2021 Result 0 infections, 25746 patient days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 25746 patient days ¹¹⁷	0.00 ¹¹⁷
Q1 2020 - Q4 2020 Result 2 infections, 25326 patient days ¹⁵⁴ Rating SIR: N/A ¹⁵⁴	2 infections, 25326 patient days ¹⁵⁴	N/A ¹⁵⁴
Q1 2019 - Q4 2019 Result 0 infections, 25428 patient days ⁴⁵ Rating SIR: N/A ⁴⁵	0 infections, 25428 patient days ⁴⁵	N/A ⁴⁵
Q1 2018 - Q4 2018 Result 0 infections, 26430 patient days ⁴⁵ Rating SIR: N/A ⁴⁵	0 infections, 26430 patient days ⁴⁵	N/A ⁴⁵
Q1 2017 - Q4 2017 Result 3 infections, 27778 patient days Rating SIR: 2.59	3 infections, 27778 patient days	2.59
Q1 2016 - Q4 2016 Result 2 infections, 30187 patient days Rating SIR: 1.55	2 infections, 30187 patient days	1.55
Q1 2015 - Q4 2015 Result 0 infections, 31722 patient days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 31722 patient days ¹¹⁷	0.00 ¹¹⁷
Q1 2014 - Q4 2014 Result 0 infections, 51722 patient days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 51722 patient days ¹¹⁷	0.00 ¹¹⁷
Q1 2013 - Q4 2013 Result 1 infections, 48662 patient days Rating SIR: 0.50	1 infections, 48662 patient days	0.50
Q1 2012 - Q4 2012 Result 3 infections, 51286 patient days Rating SIR: 1.39	3 infections, 51286 patient days	1.39
Q1 2012 - Q2 2012 Result 1 infections, 25248 patient days Rating SIR: 0.40	1 infections, 25248 patient days	0.40
Clostridioides difficile infections (CDI) Q1 2023 - Q4 2023 Result 6 infections, 23195 patient days Rating SIR: 0.52	6 infections, 23195 patient days	0.52
Description Clostridium difficile infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 10 infections, 25923 patient days Rating SIR: 0.63	10 infections, 25923 patient days	0.63
Q1 2021 - Q4 2021 Result 21 infections, 25052 patient days Rating SIR: 1.46	21 infections, 25052 patient days	1.46
Q1 2020 - Q4 2020 Result 16 infections, 24813 patient days Rating SIR: 0.92	16 infections, 24813 patient days	0.92
Q1 2019 - Q4 2019 Result 20 infections, 24686 patient days Rating SIR: 1.21	20 infections, 24686 patient days	1.21
Q1 2018 - Q4 2018 Result 17 infections, 25915 patient days Rating SIR: 1.08	17 infections, 25915 patient days	1.08
Q1 2017 - Q4 2017 Result 18 infections, 27664 patient days Rating SIR: 1.05	18 infections, 27664 patient days	1.05
Q1 2016 - Q4 2016 Result 20 infections, 30031 patient days Rating SIR: 1.04	20 infections, 30031 patient days	1.04
Q1 2015 - Q4 2015 Result 14 infections, 31278 patient days Rating SIR: 0.57	14 infections, 31278 patient days	0.57
Q1 2014 - Q4 2014 Result 23 infections, 50626 patient days Rating SIR: 0.64	23 infections, 50626 patient days	0.64
Q1 2013 - Q4 2013 Result 23 infections, 47791 patient days Rating SIR: 0.71	23 infections, 47791 patient days	0.71
Q1 2012 - Q4 2012 Result 27 infections, 50012 patient days Rating SIR: 0.80	27 infections, 50012 patient days	0.80

Adult CLABSI Measure	Result	SIR
Adult Medical/Surgical ICU Q1 2023 - Q4 2023 Result 0 infections, 812 central-line days Rating SIR: N/A	0 infections, 812 central-line days	N/A
Description Central Line-associated Bloodstream Infection data in the Adult Medical/Surgical ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 0 infections, 1171 central-line days ⁴² Rating SIR: N/A ⁴²	0 infections, 1171 central-line days ⁴²	N/A ⁴²
Q1 2021 - Q4 2021 Result 0 infections, 1621 central-line days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 1621 central-line days ¹¹⁷	0.00 ¹¹⁷
Q1 2020 - Q4 2020 Result 2 infections, 1086 central-line days Rating SIR: N/A	2 infections, 1086 central-line days	N/A
Q1 2019 - Q4 2019 Result 0 infections, 1000 central-line days ⁴² Rating SIR: N/A ⁴²	0 infections, 1000 central-line days ⁴²	N/A ⁴²
Q1 2018 - Q4 2018 Result 3 infections, 1593 central-line days Rating SIR: 2.50	3 infections, 1593 central-line days	2.50
Q1 2017 - Q4 2017 Result 1 infections, 1264 central-line days Rating SIR: 0.91	1 infections, 1264 central-line days	0.91
Q1 2016 - Q4 2016 Result 1 infections, 1433 central-line days Rating SIR: 0.80	1 infections, 1433 central-line days	0.80
Q1 2015 - Q4 2015 Result 0 infections, 1586 central-line days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 1586 central-line days ¹¹⁷	0.00 ¹¹⁷
Q1 2014 - Q4 2014 Result 0 infections, 1870 central-line days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 1870 central-line days ¹¹⁷	0.00 ¹¹⁷
Q1 2013 - Q4 2013 Result 1 infections, 1723 central-line days Rating SIR: 0.39	1 infections, 1723 central-line days	0.39
Q1 2012 - Q4 2012 Result 1 infections, 2071 central-line days Rating SIR: 0.32	1 infections, 2071 central-line days	0.32
Q1 2011 - Q4 2011 Result 2 infections, 2031 central-line days Rating SIR: 0.66	2 infections, 2031 central-line days	0.66
Q1 2010 - Q4 2010 Result 1 infections, 1484 central-line days ³⁶ Rating SIR: 0.45 ³⁶	1 infections, 1484 central-line days ³⁶	0.45 ³⁶
Q1 2009 - Q4 2009 Result 4 infections, 3574 central-line days Rating SIR: 0.75	4 infections, 3574 central-line days	0.75
Q1 2009 - Q2 2009 Result 3 infections, 1907 central-line days Rating SIR: 1.57	3 infections, 1907 central-line days	1.57

NICU CLABSI Measure	Result	SIR
Level II/III Neonatal ICU Q1 2015 - Q4 2015 Result 0 infections, 7 central-line days ³³ Rating SIR: N/A ³³	0 infections, 7 central-line days ³³	N/A ³³
Description Central Line-associated Bloodstream Infection data in the Level II/III Neonatal ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2014 - Q4 2014 Result 0 infections, 29 central-line days ³³ Rating SIR: N/A ³³	0 infections, 29 central-line days ³³	N/A ³³
Q1 2013 - Q4 2013 Result 0 infections, 1 central-line days ³³ Rating SIR: N/A ³³	0 infections, 1 central-line days ³³	N/A ³³
Q1 2012 - Q4 2012 Result 0 infections, 10 central-line days ³³ Rating SIR: 0.00 ³³	0 infections, 10 central-line days ³³	0.00 ³³
Q1 2011 - Q4 2011 Result 0 infections, 6 central-line days ³³ Rating SIR: N/A ³³	0 infections, 6 central-line days ³³	N/A ³³
Q1 2010 - Q4 2010 Result 0 infections, 11 central-line days ³⁶ Rating SIR: 0.00 ³⁶	0 infections, 11 central-line days ³⁶	0.00 ³⁶
Q1 2010 - Q2 2010 Result N/A infections, N/A central-line days ³⁶ Rating SIR: N/A ³⁶	N/A infections, N/A central-line days ³⁶	N/A ³⁶
Level III Neonatal ICU Q1 2019 - Q4 2019 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Description Central Line-associated Bloodstream Infection data in the Level III Neonatal ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2018 - Q4 2018 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Q1 2017 - Q4 2017 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Q1 2016 - Q4 2016 Result N/A infections, N/A central-line days ³⁹ Rating SIR: N/A ³⁹	N/A infections, N/A central-line days ³⁹	N/A ³⁹

SSI Measure	Result	SIR
Total Knee Replacement Surgery Q1 2020 - Q4 2020 Result 0 infections, 19 procedures ⁴⁹ Rating SIR: N/A ⁴⁹	0 infections, 19 procedures ⁴⁹	N/A ⁴⁹
Description Surgical Site Infections Associated with Total Knee Replacement Surgery Summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2019 - Q4 2019 Result 0 infections, 42 procedures ¹⁵³ Rating SIR: N/A ¹⁵³	0 infections, 42 procedures ¹⁵³	N/A ¹⁵³
Q1 2018 - Q4 2018 Result 0 infections, 51 procedures ¹⁵³ Rating SIR: N/A ¹⁵³	0 infections, 51 procedures ¹⁵³	N/A ¹⁵³
Q1 2017 - Q4 2017 Result 0 infections, 48 procedures ¹⁵³ Rating SIR: N/A ¹⁵³	0 infections, 48 procedures ¹⁵³	N/A ¹⁵³
Q1 2016 - Q4 2016 Result 0 infections, 63 procedures ¹⁵³ Rating SIR: N/A ¹⁵³	0 infections, 63 procedures ¹⁵³	N/A ¹⁵³
Q1 2015 - Q4 2015 Result 0 infections, 63 procedures ¹⁵³ Rating SIR: N/A ¹⁵³	0 infections, 63 procedures ¹⁵³	N/A ¹⁵³
Q1 2014 - Q4 2014 Result 0 infections, 93 procedures Rating SIR: N/A	0 infections, 93 procedures	N/A
Q3 2013 - Q2 2014 Result 1 infections, 113 procedures ¹¹⁴ Rating SIR: N/A ¹¹⁴	1 infections, 113 procedures ¹¹⁴	N/A ¹¹⁴
Q3 2012 - Q2 2013 Result 0 infections, 121 procedures ¹¹⁸ Rating SIR: N/A ¹¹⁸	0 infections, 121 procedures ¹¹⁸	N/A ¹¹⁸
Q3 2011 - Q2 2012 Result 1 infections, 132 procedures ⁴⁷ Rating SIR: N/A ⁴⁷	1 infections, 132 procedures ⁴⁷	N/A ⁴⁷
Q3 2010 - Q2 2011 Result 1 infections, 151 procedures ⁴⁷ Rating SIR: N/A ⁴⁷	1 infections, 151 procedures ⁴⁷	N/A ⁴⁷
Coronary Artery Bypass Graft Surgery Q1 2020 - Q4 2020 Result 0 infections, 73 procedures ¹¹⁸ Rating SIR: N/A ¹¹⁸	0 infections, 73 procedures ¹¹⁸	N/A ¹¹⁸
Description Surgical Site Infections Associated with Coronary Artery Bypass Graft Surgery Summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2019 - Q4 2019 Result 1 infections, 81 procedures ¹¹⁴ Rating SIR: N/A ¹¹⁴	1 infections, 81 procedures ¹¹⁴	N/A ¹¹⁴
Q1 2018 - Q4 2018 Result 2 infections, 107 procedures ¹¹⁴ Rating SIR: N/A ¹¹⁴	2 infections, 107 procedures ¹¹⁴	N/A ¹¹⁴
Q1 2016 - Q4 2016 Result 0 infections, 93 procedures ¹⁵³ Rating SIR: N/A ¹⁵³	0 infections, 93 procedures ¹⁵³	N/A ¹⁵³
Q1 2015 - Q4 2015 Result 2 infections, 122 procedures Rating SIR: 1.38	2 infections, 122 procedures	1.38
Q1 2014 - Q4 2014 Result 0 infections, 127 procedures Rating SIR: 0.00	0 infections, 127 procedures	0.00
Q3 2013 - Q2 2014 Result 0 infections, 138 procedures ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 138 procedures ¹¹⁷	0.00 ¹¹⁷
Q3 2012 - Q2 2013 Result 2 infections, 124 procedures Rating SIR: 1.41	2 infections, 124 procedures	1.41
Q3 2011 - Q2 2012 Result 1 infections, 135 procedures ⁴⁶ Rating SIR: 0.65 ⁴⁶	1 infections, 135 procedures ⁴⁶	0.65 ⁴⁶
Q3 2010 - Q2 2011 Result 0 infections, 138 procedures ⁴⁶ Rating SIR: 0.00 ⁴⁶	0 infections, 138 procedures ⁴⁶	0.00 ⁴⁶